A medical center has opened at the University of California, San Diego (USA) to improve phage therapy methods and conduct trials of new phage preparations – The Center for Innovative Phage Applications and Therapeutics (IPATH).
The results of the international Survey of Antibiotic Resistance (SOAR) in Ukraine and Slovakia have been published.
A rapid, sensitive, and inexpensive test for the presence of E. coli O157:H7 in food samples has been developed in the United States. The test's main component is a genetically modified bacteriophage.
The war between bacteriophages and bacteria has been going on for billions of years. Learn more about it in this popular video from the "Interesting Science" project.
While bacteriophages were previously viewed simply as "bacteria killers," it is now known that they play a vital role in the functioning of the immune system. Phages have anti-inflammatory effects and can reduce allergic reactions.
The 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018 was held in Florence, Italy, on May 17–18, 2018.
Recently, a community of microorganisms (microbiome) in the urinary tract of women was discovered and described. It was later discovered that, in addition to bacteria, it also includes numerous bacteriophages.
Research into the colistin resistance gene has shown that it emerged in 2005 in China, in pigs, and then spread very quickly around the world.
A cocktail containing three bacteriophages successfully dealt with virtually all tested Escherichia coli strains without affecting beneficial intestinal microflora.
When studying the interaction of C. difficile An interesting phenomenon was discovered with the bacteriophage phiCDHS1 in a human cell culture: human cells increased the antimicrobial activity of phages
In 2017, so-called "nightmare bacteria" with a particularly rare antibiotic resistance gene were identified more than 220 times in the United States.
Infection plays a key role in the pathogenesis of diabetic foot disease. Among the pathogens, antibiotic-resistant bacterial strains are becoming increasingly common.
The FDA has approved clinical trials of phage therapy for Crohn's disease. This move could facilitate the entry of other phage therapies into the U.S. market.
In the US, a patient with an aortic arch prosthesis infection that was resistant to antibiotics was saved using bacteriophages.
A group of scientists from the University of Helsinki (Finland) and Seoul National University (South Korea) investigated the possibility of using bacteriophages to eradicate such a food pathogen as Yersinia enterocolitica
To discuss phage therapy issues, a Symposium on the Use of Bactriophages in Clinical Practice will be held in Utrecht, the Netherlands, on February 22, 2018. Leading international experts in the field of phage therapy have been invited to the Symposium.
The WHO has published the first data collected by the Global Antimicrobial Resistance Surveillance System (GLASS). High levels of antibiotic resistance have been recorded across a range of serious bacterial infections in both high- and low-income countries.
Physicists from the University of Jyväskylä (Finland) used helium microscopy to study the behavior of bacteriophages: they obtained images of various stages of phage infection of bacteria.
